We have located links that may give you full text access.
Validation of the Dutch version of the Breakthrough Pain Assessment Tool in Patients with Cancer.
Journal of Pain and Symptom Management 2019 December 24
CONTEXT: Essential for adequate management of breakthrough cancer pain is a combination of accurate (re-)assessment and a personalized treatment plan. The Breakthrough pain Assessment Tool (BAT) has been proven to be a brief, multidimensional, reliable and valid questionnaire for the assessment of breakthrough cancer pain.
OBJECTIVES: The aim of this study was to examine the validity and reliability of the Dutch Language version of the BAT (BAT-DL) in patients with cancer.
METHODS: The BAT was forward-backward translated into the Dutch language. Thereafter, the psychometric properties of the BAT-DL were tested, i.e. factor structure, reliability (internal consistency, test-retest reliability) and validity (content validity, construct validity) and the responsiveness to change.
RESULTS: The BAT-DL confirmed the two-factor structure in 170 patients with cancer: pain severity/ impact factor, and pain duration/ medication efficacy factor. The Cronbach's alpha coefficient was 0.72, and the intraclass correlation for the test-retest reliability was 0.81. The BAT-DL showed to be able to differentiate between different group of patients, and correlated significantly with the Brief Pain Inventory. Additionally, the BAT-DL was capable to detect clinically important changes over time.
CONCLUSION: The BAT-DL is a valid and reliable questionnaire to assess breakthrough pain in Dutch patients with cancer, and is a relevant questionnaire for daily practice.
OBJECTIVES: The aim of this study was to examine the validity and reliability of the Dutch Language version of the BAT (BAT-DL) in patients with cancer.
METHODS: The BAT was forward-backward translated into the Dutch language. Thereafter, the psychometric properties of the BAT-DL were tested, i.e. factor structure, reliability (internal consistency, test-retest reliability) and validity (content validity, construct validity) and the responsiveness to change.
RESULTS: The BAT-DL confirmed the two-factor structure in 170 patients with cancer: pain severity/ impact factor, and pain duration/ medication efficacy factor. The Cronbach's alpha coefficient was 0.72, and the intraclass correlation for the test-retest reliability was 0.81. The BAT-DL showed to be able to differentiate between different group of patients, and correlated significantly with the Brief Pain Inventory. Additionally, the BAT-DL was capable to detect clinically important changes over time.
CONCLUSION: The BAT-DL is a valid and reliable questionnaire to assess breakthrough pain in Dutch patients with cancer, and is a relevant questionnaire for daily practice.
Full text links
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app